ReviewFrontiers in endocrinology2026
Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Improved survival of pediatric and adolescent patients with hematologic malignancies has shifted attention toward long-term quality-of-life outcomes, including fertility. Female survivors of leukemia and lymphoma are at high risk of gonadal and uterine damage due to exposure to alkylating agents, radiotherapy, and hematopoietic stem cell transplantation, resulting in premature ovarian insufficiency, diminished ovarian reserve, and adverse pregnancy outcomes. Concurrently, fertility preservation strategies have evolved, expanding options for both prepubertal and postpubertal patients. This narrative review summarizes the impact of contemporary hematologic treatments on female reproductive function and critically appraises current fertility preservation approaches, including oocyte cryopreservation, ovarian tissue cryopreservation, ovarian transposition, and pharmacologic ovarian suppression. We also review evidence on spontaneous fertility and pregnancy outcomes in survivors and discuss the specific challenges associated with hematologic malignancies, such as treatment urgency and the risk of malignant cell reintroduction following ovarian tissue transplantation. Finally, emerging strategies, including artificial ovary construction and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.